Literature DB >> 2165944

Coxsackie B4 viruses with the potential to damage beta cells of the islets are present in clinical isolates.

T M Szopa1, T Ward, D M Dronfield, N D Portwood, K W Taylor.   

Abstract

Infections with Coxsackie viruses (especially Coxsackie B4) are thought to be involved in the pathogenesis of diabetes. Many interdependent variables determine the outcome of an infection with a Coxsackie virus, one of them being the tropism of the virus for a specific tissue. The extent to which Beta cell tropic variants of Coxsackie B4 virus occur naturally was assessed. Human isolates of this virus were tested in an in vitro system in which elevated insulin release from infected islets incubated at a non-stimulatory (2 mmol/l) glucose concentration appears to be related to viral attack. Using this technique, 8/24 isolates tested, impaired secretory function in mouse islets. Some strains of Coxsackie B4 virus, therefore, will directly infect mouse islets in vitro leading to changes in islet cell function. In conclusion, these findings confirm that variants of Coxsackie B4 virus with the potential to damage Beta cells occur quite frequently in the natural population. In certain circumstances the damage they inflict on Beta cells may cause destruction of these cells, or precipitate overt diabetes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2165944     DOI: 10.1007/BF00404634

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  25 in total

1.  Immunoassay of insulin with insulin-antibody precipitate.

Authors:  C N HALES; P J RANDLE
Journal:  Biochem J       Date:  1963-07       Impact factor: 3.857

2.  The complete nucleotide sequence of coxsackievirus B4 and its comparison to other members of the Picornaviridae.

Authors:  O Jenkins; J D Booth; P D Minor; J W Almond
Journal:  J Gen Virol       Date:  1987-07       Impact factor: 3.891

3.  Virus-induced pancreatic disease: alterations in concentration of glucose and amylase in blood.

Authors:  M E Ross; K Hayashi; A L Notkins
Journal:  J Infect Dis       Date:  1974-06       Impact factor: 5.226

4.  Pathogenicity of the M and E variants of the encephalomyocarditis (EMC) virus. I. Myocardiotropic and neurotropic properties.

Authors:  J E Craighead
Journal:  Am J Pathol       Date:  1966-02       Impact factor: 4.307

5.  Diabetes and Coxsackie virus B5 infection.

Authors:  H Champsaur; E Dussaix; D Samolyk; M Fabre; C Bach; R Assan
Journal:  Lancet       Date:  1980-02-02       Impact factor: 79.321

6.  High frequency of antigenic variants among naturally occurring human Coxsackie B4 virus isolates identified by monoclonal antibodies.

Authors:  B S Prabhakar; M V Haspel; P R McClintock; A L Notkins
Journal:  Nature       Date:  1982-11-25       Impact factor: 49.962

7.  Coxsackie virus B4 produces transient diabetes in nonhuman primates.

Authors:  J W Yoon; W T London; B L Curfman; R L Brown; A L Notkins
Journal:  Diabetes       Date:  1986-06       Impact factor: 9.461

8.  Coxsackie B4 virus induces short-term changes in the metabolic functions of mouse pancreatic islets in vitro.

Authors:  T M Szopa; D R Gamble; K W Taylor
Journal:  Cell Biochem Funct       Date:  1986-07       Impact factor: 3.685

9.  [Myocarditis and insulitis following coxsackie virus infection].

Authors:  R Gladisch; W Hofmann; R Waldherr
Journal:  Z Kardiol       Date:  1976-10

10.  Diabetogenic potential of coxsackie B viruses in nature.

Authors:  G W Jordan; V Bolton; N J Schmidt
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

View more
  14 in total

Review 1.  Molecular mimicry in autoimmune disease.

Authors:  S Leech
Journal:  Arch Dis Child       Date:  1998-11       Impact factor: 3.791

2.  Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells.

Authors:  W Chehadeh; J Kerr-Conte; F Pattou; G Alm; J Lefebvre; P Wattré; D Hober
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

Review 3.  Prospects for the prevention and reversal of type 1 diabetes mellitus.

Authors:  Nikolai Petrovsky; Diego Silva; Desmond A Schatz
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 4.  Environmental triggers and determinants of beta-cell autoimmunity and type 1 diabetes.

Authors:  Mikael Knip
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

Review 5.  Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host.

Authors:  Didier Hober; Pierre Sauter
Journal:  Nat Rev Endocrinol       Date:  2010-03-30       Impact factor: 43.330

6.  Molecular analysis of an echovirus 3 strain isolated from an individual concurrently with appearance of islet cell and IA-2 autoantibodies.

Authors:  Ciğdem H Williams; Sami Oikarinen; Sisko Tauriainen; Kimmo Salminen; Heikki Hyöty; Glyn Stanway
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

Review 7.  Diabetes mellitus due to viruses--some recent developments.

Authors:  T M Szopa; P A Titchener; N D Portwood; K W Taylor
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

8.  WIN 54954 treatment of mice infected with a diabetogenic strain of group B coxsackievirus.

Authors:  D M See; J G Tilles
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

9.  Simultaneous onset of type 1 diabetes in monozygotic twins younger than 1 year.

Authors:  Noriko Uchida; Yoshiro Amano; Yohei Akazawa; Shinichi Nakamura; Isaki Minami; Kazuhiko Washizawa; Yasunobu Wakabayashi; Kozo Yasui
Journal:  Eur J Pediatr       Date:  2007-03-15       Impact factor: 3.183

10.  Diabetes: have we got it all wrong? Insulin hypersecretion and food additives: cause of obesity and diabetes?

Authors:  Barbara E Corkey
Journal:  Diabetes Care       Date:  2012-12       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.